StockData
Cumberland Pharmaceuticals Inc logo

Cumberland Pharmaceuticals Inc (CPIX) stock

CPIXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30225% above fair value
$5.80+0.59 (+11.32%)

Close on Nov 17, 2026Market cap $86.90MP/E –Yield –

Cumberland Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Cumberland Pharmaceuticals's revenue for the twelve months ending Jun 30, 2026 was $31.27M, down 1.1% year over year. For fiscal 2025 it was $44.52M, up 17.6% from the year before. Over ten years it grew 47.7% a year on average. The highest annual figure on record is $51.14M in fiscal 2011.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$44.52M+17.6%
FY2024Dec 31, 2024$37.87M-4.3%
FY2023Dec 31, 2023$39.55M-5.9%
FY2022Dec 31, 2022$42.01M+16.7%
FY2021Dec 31, 2021$35.99M-3.9%
FY2020Dec 31, 2020$37.44M+8.9%
FY2019Dec 31, 2019$34.39M+17.2%
FY2018Dec 31, 2018$29.34M-28.7%
FY2017Dec 31, 2017$41.15M+24.6%
FY2016Dec 31, 2016$33.03M+3569.5%
FY2015Dec 31, 2015$900.00K+50.0%
FY2014Dec 31, 2014$600.00K-25.0%
FY2013Dec 31, 2013$800.00K+14.3%
FY2012Dec 31, 2012$700.00K-98.6%
FY2011Dec 31, 2011$51.14M+11.5%
FY2010Dec 31, 2010$45.88M+5.4%
FY2009Dec 31, 2009$43.54M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$166.46K-56.3%
Q1 FY2026Mar 31, 2026$9.13M-22.0%
Q4 FY2025Dec 31, 2025$13.68M+31.1%
Q3 FY2025Sep 30, 2025$8.29M-8.7%
Q2 FY2025Jun 30, 2025$380.80K-96.1%
Q1 FY2025Mar 31, 2025$11.71M+37.8%
Q4 FY2024Dec 31, 2024$10.44M+11.6%
Q3 FY2024Sep 30, 2024$9.09M-9.9%
Q2 FY2024Jun 30, 2024$9.85M-9.6%
Q1 FY2024Mar 31, 2024$8.50M-7.9%
Q4 FY2023Dec 31, 2023$9.35M+2.5%
Q3 FY2023Sep 30, 2023$10.09M-11.6%
Q2 FY2023Jun 30, 2023$10.89M+5.7%
Q1 FY2023Mar 31, 2023$9.22M-17.5%
Q4 FY2022Dec 31, 2022$9.12M+9.7%
Q3 FY2022Sep 30, 2022$11.41M+41.4%
Q2 FY2022Jun 30, 2022$10.30M+13.7%
Q1 FY2022Mar 31, 2022$11.18M+6.1%
Q4 FY2021Dec 31, 2021$8.32M-18.9%
Q3 FY2021Sep 30, 2021$8.07M-12.7%
Q2 FY2021Jun 30, 2021$9.06M-5.7%
Q1 FY2021Mar 31, 2021$10.54M+26.5%
Q4 FY2020Dec 31, 2020$10.26M+10.3%
Q3 FY2020Sep 30, 2020$9.25M+33.4%
Q2 FY2020Jun 30, 2020$9.60M+1.9%
Q1 FY2020Mar 31, 2020$8.33M-4.6%
Q4 FY2019Dec 31, 2019$9.31M-31.1%
Q3 FY2019Sep 30, 2019$6.94M-18.3%
Q2 FY2019Jun 30, 2019$9.42M-7.3%
Q1 FY2019Mar 31, 2019$8.73M+1.7%
Q4 FY2018Dec 31, 2018$13.50M+15.9%
Q3 FY2018Sep 30, 2018$8.49M-24.2%
Q2 FY2018Jun 30, 2018$10.16M+17.3%
Q1 FY2018Mar 31, 2018$8.59M-10.9%
Q4 FY2017Dec 31, 2017$11.65M+28.3%
Q3 FY2017Sep 30, 2017$11.20M+27.4%
Q2 FY2017Jun 30, 2017$8.67M–
Q1 FY2017Mar 31, 2017$9.64M–
Q4 FY2016Dec 31, 2016$9.08M–
Q3 FY2016Sep 30, 2016$8.79M–

More Cumberland Pharmaceuticals figures

See a number that looks wrong?